Supportive evidence for the importance of the IFN pathway in the development of T1D further derives from studies demonstrating that aberrant IFN responses triggered either by genetic mutations in key pathways [57] or the activation of components upstream of IFNs [58] are also associated with disease. The gene discussed is IFNA1; the disease is type 1 diabetes mellitus.